Back to Search
Start Over
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.
- Source :
-
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Sep 01; Vol. 24 (17), pp. 4175-4186. Date of Electronic Publication: 2018 Feb 07. - Publication Year :
- 2018
-
Abstract
- Purpose: T-cell dysfunction is a hallmark of glioblastoma (GBM). Although anergy and tolerance have been well characterized, T-cell exhaustion remains relatively unexplored. Exhaustion, characterized in part by the upregulation of multiple immune checkpoints, is a known contributor to failures amid immune checkpoint blockade, a strategy that has lacked success thus far in GBM. This study is among the first to examine, and credential as bona fide , exhaustion among T cells infiltrating human and murine GBM. Experimental Design: Tumor-infiltrating and peripheral blood lymphocytes (TILs and PBLs) were isolated from patients with GBM. Levels of exhaustion-associated inhibitory receptors and poststimulation levels of the cytokines IFNγ, TNFα, and IL2 were assessed by flow cytometry. T-cell receptor Vβ chain expansion was also assessed in TILs and PBLs. Similar analysis was extended to TILs isolated from intracranial and subcutaneous immunocompetent murine models of glioma, breast, lung, and melanoma cancers. Results: Our data reveal that GBM elicits a particularly severe T-cell exhaustion signature among infiltrating T cells characterized by: (1) prominent upregulation of multiple immune checkpoints; (2) stereotyped T-cell transcriptional programs matching classical virus-induced exhaustion; and (3) notable T-cell hyporesponsiveness in tumor-specific T cells. Exhaustion signatures differ predictably with tumor identity, but remain stable across manipulated tumor locations. Conclusions: Distinct cancers possess similarly distinct mechanisms for exhausting T cells. The poor TIL function and severe exhaustion observed in GBM highlight the need to better understand this tumor-imposed mode of T-cell dysfunction in order to formulate effective immunotherapeutic strategies targeting GBM. Clin Cancer Res; 24(17); 4175-86. ©2018 AACR See related commentary by Jackson and Lim, p. 4059 .<br /> (©2018 American Association for Cancer Research.)
- Subjects :
- Adult
Aged
Aged, 80 and over
Animals
CD8-Positive T-Lymphocytes immunology
Female
Flow Cytometry
Gene Expression Regulation, Neoplastic immunology
Glioblastoma genetics
Glioblastoma pathology
Humans
Interferon-gamma genetics
Interleukin-2 genetics
Lymphocytes, Tumor-Infiltrating pathology
Male
Mice
Middle Aged
Receptors, Antigen, T-Cell, alpha-beta genetics
T-Lymphocytes pathology
Tumor Microenvironment immunology
Tumor Necrosis Factor-alpha genetics
Glioblastoma immunology
Lymphocytes, Tumor-Infiltrating immunology
Receptors, Antigen, T-Cell, alpha-beta immunology
T-Lymphocytes immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1557-3265
- Volume :
- 24
- Issue :
- 17
- Database :
- MEDLINE
- Journal :
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Publication Type :
- Academic Journal
- Accession number :
- 29437767
- Full Text :
- https://doi.org/10.1158/1078-0432.CCR-17-1846